These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8930118)
21. Allele-specific overexpression in astrocytes of an Alzheimer's disease associated alpha-1-antichymotrypsin promoter polymorphism. Ritchie A; Morgan K; Kalsheker N Brain Res Mol Brain Res; 2004 Nov; 131(1-2):88-92. PubMed ID: 15530656 [TBL] [Abstract][Full Text] [Related]
22. Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Abraham CR; Shirahama T; Potter H Neurobiol Aging; 1990; 11(2):123-9. PubMed ID: 2190106 [TBL] [Abstract][Full Text] [Related]
24. Alpha 1-antichymotrypsin in brain aging and disease. Abraham CR; Potter H Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582 [TBL] [Abstract][Full Text] [Related]
25. Multi-functional capability of proteins: alpha1-antichymotrypsin and the correlation with Alzheimer's disease. Zhang S; Janciauskiene S J Alzheimers Dis; 2002 Apr; 4(2):115-22. PubMed ID: 12214135 [No Abstract] [Full Text] [Related]
26. Multiple functions of alpha 1-antitrypsin and alpha 1-antichymotrypsin. 2. Role of serpins and their target enzymes in controlling neutrophil chemotaxis. Luisetti M Monaldi Arch Chest Dis; 1997 Feb; 52(1):48-9. PubMed ID: 9151521 [No Abstract] [Full Text] [Related]
27. Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. Shoji M; Hirai S; Yamaguchi H; Harigaya Y; Ishiguro K; Matsubara E Am J Pathol; 1991 Jan; 138(1):247-57. PubMed ID: 1702930 [TBL] [Abstract][Full Text] [Related]
28. alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity. Aksenova MV; Aksenov MY; Butterfield DA; Carney JM Neurosci Lett; 1996 Jun; 211(1):45-8. PubMed ID: 8809844 [TBL] [Abstract][Full Text] [Related]
29. Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema. Chang WS; Lomas DA J Biol Chem; 1998 Feb; 273(6):3695-701. PubMed ID: 9452500 [TBL] [Abstract][Full Text] [Related]
30. A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. Rozemuller JM; Eikelenboom P; Stam FC; Beyreuther K; Masters CL J Neuropathol Exp Neurol; 1989 Nov; 48(6):674-91. PubMed ID: 2677252 [TBL] [Abstract][Full Text] [Related]
31. Multiple functions of alpha 1-antitrypsin and alpha 1-antichymotrypsin. 3. Regulation of extracellular surfactant metabolism and amyloid fibril formation. Luisetti M Monaldi Arch Chest Dis; 1997 Jun; 52(3):285-6. PubMed ID: 9270259 [No Abstract] [Full Text] [Related]
32. Structural change in alpha-chymotrypsin induced by complexation with alpha 1-antichymotrypsin as seen by enhanced sensitivity to proteolysis. Stavridi ES; O'Malley K; Lukacs CM; Moore WT; Lambris JD; Christianson DW; Rubin H; Cooperman BS Biochemistry; 1996 Aug; 35(33):10608-15. PubMed ID: 8718849 [TBL] [Abstract][Full Text] [Related]
33. Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)-antichymotrypsin in astrocytes: significance for Alzheimer's disease. Nilsson LN; Das S; Potter H Neurochem Int; 2001; 39(5-6):361-70. PubMed ID: 11578771 [TBL] [Abstract][Full Text] [Related]
34. The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease. Faber JP; Poller W; Olek K; Baumann U; Carlson J; Lindmark B; Eriksson S J Hepatol; 1993 Jul; 18(3):313-21. PubMed ID: 8228125 [TBL] [Abstract][Full Text] [Related]
35. Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Mahadeva R; Sharples L; Ross-Russell RI; Webb AK; Bilton D; Lomas DA Thorax; 2001 Jan; 56(1):53-8. PubMed ID: 11120905 [TBL] [Abstract][Full Text] [Related]
36. Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells. Sun YX; Wright HT; Janciauskiene S J Neurosci Res; 2002 Feb; 67(4):511-22. PubMed ID: 11835318 [TBL] [Abstract][Full Text] [Related]
37. Characterization of the serpin, alpha 1-antichymotrypsin, in normal human cerebrospinal fluid. Rayford A; Rao JS; Festoff BW J Neurochem; 1992 Jan; 58(1):88-94. PubMed ID: 1727448 [TBL] [Abstract][Full Text] [Related]
38. alpha 1-Proteinase inhibitor, alpha 1-antichymotrypsin, and alpha 2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells. Ikari Y; Mulvihill E; Schwartz SM J Biol Chem; 2001 Apr; 276(15):11798-803. PubMed ID: 11096092 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of human chymotrypsin-like proteases by alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin. Hayem A; Marko D; Laine A; Davril M Adv Exp Med Biol; 1988; 240():97-9. PubMed ID: 3266711 [No Abstract] [Full Text] [Related]
40. Synthesis and secretion of active alpha 1-antichymotrypsin by murine primary astrocytes. Kanemaru K; Meckelein B; Marshall DC; Sipe JD; Abraham CR Neurobiol Aging; 1996; 17(5):767-71. PubMed ID: 8892350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]